IDH1 and central nervous system cancer: Watanabe et al. [11] observed that there was no case in which IDH mutation occurred after the acquisition of either TP53 mutation or loss of 1p/19q co-deletion, suggesting that IDH1 mutations are very early events in glioma genesis and may affect a common glial precursor.